AHA 2023 CardioNerds Conference Scholars Late-Breaking Video Collection

Published: 16 November 2023

  • Views:

    Views Icon 1862
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

In 2023, we are excited to partner with @CardioNerds, a dynamic team dedicated to democratizing cardiovascular education. Experience a fresh perspective on the new data through an interview series featuring principal investigators and ambassadors from the CardioNerds family. 

 

These interviews are supported by an educational grant from Novo Nordisk Inc. This content is not intended for UK HCPs.

About the episode

AHA 2023 — Investigator, Dr Jeffrey Carson (Rutgers University, US) joined Dr Nazli Okumus, CardioNerds Ambassador to discuss findings from the MINT trial (NCT02981407). 

 

The aim of this randomised, parallel assignment trial (Rutgers) is to compare liberal and restrictive red blood cell transfusion strategies in patients who have had an acute myocardial infarction (AMI) and are anemic. Investigators enrolled 3,506 patients with AMI and a hemoglobin level less than 10 g/dL at 144 centers in the United States, Canada, France, Brazil, New Zealand and Australia. Patients will be randomized to either a liberal or restrictive transfusion strategy. The primary endpoint is a composite of all-cause death or recurrent MI within 30 days following randomization.

 

Findings presented at AHA showed that the MINT trial did not demonstrate a statistically significant recurrence in the rate of 30-day death or recurrent MI in patients with acute MI and anaemia assigned to a restrictive transfusion strategy as compared to a liberal strategy. While not statistically significant, point estimates for the primary outcome and secondary outcomes consistently favoured a liberal transfusion strategy. 

 

Recorded on-site at AHA 2023, Philadelphia.

 

Supported by an educational grant from Novo Nordisk Inc. This content is not intended for UK HCPs.

Faculty Biographies

Nazli Okumus

Nazli Okumus

Dr. Nazli Okumus is currently in her third year as a Cardiology Fellow at Allegheny Health Network (AHN) in Pittsburgh, PA, where she is dedicated to advancing her training in interventional cardiology. She successfully completed her residency at Case Western MetroHealth in Cleveland, OH. Her commitments extend to serving as a member of the SCAI Political Action Committee, contributing to the ACC FIT Editorial Fellowship program Advocacy section, and acting as the CardioNerds Ambassador, representing her fellowship program while participating in the CardioNerds IC and CCC committees. In addition, she is actively engaged in digital education and mentorship, with a particular emphasis on empowering women in medicine. Her research and clinical interests encompass cardiogenic shock, valvular heart disease, and complex coronary interventions. Dr. Okumus is fervently committed to patient advocacy and addressing health disparities.

View full profile
Jeffrey Carson

Jeffrey Carson

Dr Jeffrey Carson, currently serving as the Provost, New Brunswick at Rutgers Biomedical and Health Sciences, brings a wealth of experience and leadership to the field of medicine. Formerly the Chief of the Division of General Internal Medicine until 2015, he holds the esteemed position of Distinguished Professor of Medicine and occupies the Richard C. Reynolds, M.D. Chair in General Internal Medicine.

Dr Carson earned his MD degree from Hahnemann Medical College, where he also undertook residency and served as Chief Resident in Internal Medicine. His commitment to advancing medical knowledge is evident in his research training in clinical epidemiology during a prestigious two-year Henry J. Kaiser Fellowship at the University of Pennsylvania. Further enhancing his expertise, Dr. Carson became a Fogarty Senior International Fellow at the University of Oxford, England, from 1995–1996, receiving extensive training in clinical trials.

As a board-certified internist…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.